Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LYEL compared with VIR: revenue, margins and what each company keeps, and the suppliers and customers both name
LYEL
Lyell Immunopharma, Inc.
Change
Mkt cap
Revenue
Revenue
VIR
Vir Biotechnology, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LYEL
Lyell Immunopharma, Inc.
vs
VIR
Vir Biotechnology, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
LYEL
with
VIR
No shared trading history for LYEL and VIR.
Shared co-movers: not yet measured (LYEL).
LYEL, solid
VIR, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
LYEL
Lyell Immunopharma, Inc.
Change
14.95
▼
−3.09%
Mkt cap
$378.1M
Revenue
$3,000
Q3 FY26
Revenue
$36,000
FY25
VIR
Vir Biotechnology, Inc.
Change
11.23
▼
−4.59%
Regular session
Nov 5 '26
Mkt cap
$2.0B
Revenue
$239M
Q2 FY26
Revenue
$74M
FY24
vs
Compare
Regular session
Nov 5 '26
LYEL
Lyell Immunopharma, Inc.
vs
VIR
Vir Biotechnology, Inc.
14.95
▼
−3.09%
Price
11.23
▼
−4.59%
$378.1M
Mkt cap
$2.0B
Q3 FY26
$3,000
Revenue
$239M
Q2 FY26
FY25
$36,000
Revenue
$74M
FY24
Change
Change
LYEL
14.95
▼
−3.09%
vs
VIR
11.23
▼
−4.59%
Regular session
Nov 5 '26